| pubmed-article:20447549 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C0025914 | lld:lifeskim |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C1418946 | lld:lifeskim |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C0699790 | lld:lifeskim |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C0205147 | lld:lifeskim |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C0699759 | lld:lifeskim |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
| pubmed-article:20447549 | lifeskim:mentions | umls-concept:C1828021 | lld:lifeskim |
| pubmed-article:20447549 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20447549 | pubmed:dateCreated | 2010-5-7 | lld:pubmed |
| pubmed-article:20447549 | pubmed:abstractText | (64)Cu-diacetyl-bis (N(4)-methylthiosemicarbazone) ((64)Cu-ATSM) is a potential imaging agent of hypoxic tumor for use with PET. Recent literature demonstrated that cancer cells expressing CD133, which is a frequently used marker for so-called cancer stem cells or cancer stem cell-like cells (collectively referred to here as CSCs), contribute to tumor's therapeutic resistance and metastasis ability. Culturing under hypoxia is also reported to enlarge the proportion of CD133(+) cells, which would indicate survival advantage of CD133(+) cells under hypoxia. Here, we investigated the relationships between (64)Cu-ATSM accumulation and existence of CD133(+) cells using mouse colon carcinoma (colon-26) tumor. | lld:pubmed |
| pubmed-article:20447549 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20447549 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20447549 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20447549 | pubmed:month | May | lld:pubmed |
| pubmed-article:20447549 | pubmed:issn | 1872-9614 | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:WelchMichael... | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:FujibayashiYa... | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:FurukawaTakak... | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:AsaiTatsuyaT | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:WakiAtsuoA | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:OkazawaHidehi... | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:MoriTetsuyaT | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:KiyonoYasushi... | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:WatanabeRyoR | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:OhMyungmiM | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:YoshiiHiroshi... | lld:pubmed |
| pubmed-article:20447549 | pubmed:author | pubmed-author:YoshiiYukieY | lld:pubmed |
| pubmed-article:20447549 | pubmed:copyrightInfo | (c) 2010 Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:20447549 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20447549 | pubmed:volume | 37 | lld:pubmed |
| pubmed-article:20447549 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20447549 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20447549 | pubmed:pagination | 395-404 | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:meshHeading | pubmed-meshheading:20447549... | lld:pubmed |
| pubmed-article:20447549 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20447549 | pubmed:articleTitle | Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma. | lld:pubmed |
| pubmed-article:20447549 | pubmed:affiliation | Biomedical Imaging Research Center, University of Fukui, Eiheiji, Fukui 910-1193, Japan. | lld:pubmed |
| pubmed-article:20447549 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20447549 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
